Manufacturing

Articles

AkesoBio’s expanded manufacturing capacity, enabled by the addition of another Cytiva FlexFactory platform, will be used to meet current and future market needs in China as well as worldwide.

Cytiva Provides Another FlexFactory Single-Use Platform for AkesoBio’s Manufacturing Expansion

Cynthia A. Challener, PhD, is a contributing editor to BioPharm International.

Biopharmaceutical companies and contract manufacturers respond to changing demand dynamics for upstream bioprocessing capacity.

Maximum Output Starts with Optimized Upstream Processing

Feliza Mirasol is the science editor for 

The innovation of single-use technologies is applicable early on in the manufacturing process.

Single-Use Bags Help Maintain Aseptic Ingredient Transfer to Bioreactors

The adoption of single-use technologies in fluid-handling systems helps streamline downstream bioprocessing operations.

Fluid Handling Systems are Seeing Benefit from Single-Use Technologies

The availability of materials is a critical factor when it comes to vaccine capacity.

Supply Chain Challenges Creating Hurdles to COVID-19 Vaccine Production

The investments are expected to double Thermo Fisher’s manufacturing capacity while creating more than 1500 jobs at 11 manufacturing sites in the Americas, Europe, and Asia.

Thermo Fisher to Invest More than $600 Million into Bioprocessing Production Expansions 

Cytiva’s new facility in Shrewsbury, MA will make equipment such as single-use bioreactors. 


Cytiva Opens New Manufacturing Facility in Massachusetts

Cytiva is adding process development, media and assay development, and contract development services at its facilities in Korea, Japan, Sweden, and the UK.

Cytiva Expands Cell and Gene Therapy Fast Trak Services

Set to be operational by the first quarter of 2022, the 140,000-ft2 facility will feature up to six 2000-L, single-use bioreactor systems along with additional harvest and purification equipment to produce up to 100 commercial batches annually. 

KBI Biopharma to Open $150 Million Commercial Manufacturing Facility in North Carolina

Biopharma can apply new manufacturing practices adopted during the COVID-19 pandemic to enhance bioprocessing.

Manufacturing Systems, Single-Use